Maria Angelica Linton

age ~59

from San Diego, CA

Get Report

Also known as:

Maria A Linton
Angelica P Linton
Angelica Rivera
Angelic A Rivera

Phone and address:: 10256 Rue Chamberry, San Diego, CA 92131
(858)6898663

Connected to:

Maria Linton Phones & Addresses

10256 Rue Chamberry, San Diego, CA 92131 • (858)6898663
Houston, TX
10256 Rue Chamberry, San Diego, CA 92131

Work

Company:

Therapy specialists
Apr 2018
Position:

Rehabilitation technician

Education

Degree:

Bachelors
School / High School:

University of California, Davis
2013 to 2017
Specialities:

Physiology

Skills

Spanish • Microsoft Word • Microsoft Excel • Microsoft Office • Teamwork • Powerpoint • Social Media • Public Speaking • Research • Leadership • Community Outreach • Data Analysis • Event Planning

Languages

English • Spanish

Interests

Children • Civil Rights and Social Action • Science and Technology • Human Rights • Health

Emails

m***[email protected]

Industries

Health, Wellness And Fitness

Resumes

Student In Doctor Of Occupational

view source

Location:

Charlestown, MA

Industry:

Health, Wellness And Fitness

Work:

Therapy Specialists
Rehabilitation Technician
Behavior Frontiers Jun 2017 - Mar 2018
Behavior Instructor
Uc Davis Sep 2015 - Jun 2017
Peer Buddy and Outreach Coordinator
Uc Davis Mind Institute Jan 2016 - Dec 2016
Research Assistant
Global Medical Brigades at Uc Davis Sep 2013 - Jun 2016
Vice President

Education:

University of California, Davis 2013 - 2017
Bachelors, Physiology Scripps Ranch High School 2013
Mgh Institute of Health Professions

Skills:

Spanish
Microsoft Word
Microsoft Excel
Microsoft Office
Teamwork
Powerpoint
Social Media
Public Speaking
Research
Leadership
Community Outreach
Data Analysis
Event Planning

Interests:

Children
Civil Rights and Social Action
Science and Technology
Human Rights
Health

Languages:

English
Spanish

Us Patents

Hiv Protease Inhibitors, Compositions Containing The Same, Their Pharmaceutical Uses And Materials For Their Synthesis
view source
US Patent:

6953858, Oct 11, 2005
Filed:

Jun 11, 2002
Appl. No.:

10/166957
Inventors:

Stacie S. Canan Koch - La Jolla CA, US
Therese N. Alexander - San Diego CA, US
Mark Barvian - Ann Arbor MI, US
Gary Bolton - Ann Arbor MI, US
Benjamin J. Burke - San Diego CA, US
Tod Holler - Ann Arbor MI, US
Tanya M. Jewell - Encinitas CA, US
Vara Prasad Josyula - Ann Arbor MI, US
David J. Kucera - Del Mar CA, US
Maria Angelica Linton - San Diego CA, US
Jeffrey J. Machak - Shelby Township MI, US
Sean T. Murphy - Ypsilanti MI, US
Siegfried H. Reich - Solana Beach CA, US
Donald J. Skalitzky - San Diego CA, US
John H. Tatlock - San Diego CA, US
Michael D. Varney - Solana Beach CA, US
Scott C. Virgil - San Diego CA, US
Stephen E. Webber - San Diego CA, US
Stephen T. Worland - Del Mar CA, US
Michael Melnick - Ann Arbor MI, US
Assignee:

Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:

C07D277/06
US Classification:

548200
Abstract:

Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase
view source
US Patent:

7115658, Oct 3, 2006
Filed:

May 9, 2003
Appl. No.:

10/434702
Inventors:

Allen J. Borchardt - San Diego CA, US
Peter Scott Dragovich - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Ru Zhou - Carlsbad CA, US
Thomas Jay Prins - Cardiff CA, US
Melwyn A. Abreo - Jamul CA, US
Assignee:

Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:

A61K 31/351
US Classification:

514460, 514459, 514336, 514365, 514452, 514364, 514378, 514405, 514326, 5142315, 514422, 51425931, 514384, 514397, 5142621, 514456, 5142581, 514382, 51425505, 514369, 514274, 514340, 514363, 514375, 5142541
Abstract:

Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.

Hiv Protease Inhibitors, Compositions Containing The Same, Their Pharmaceutical Uses And Materials For Their Synthesis
view source
US Patent:

7179918, Feb 20, 2007
Filed:

Jun 11, 2002
Appl. No.:

10/166979
Inventors:

Stacie S. Canan Koch - La Jolla CA, US
Therese N. Alexander - San Diego CA, US
Benjamin J. Burke - San Diego CA, US
Tanya M. Jewell - Encinitas CA, US
David J. Kucera - Del Mar CA, US
Maria Angelica Linton - San Diego CA, US
Siegfried H. Reich - Solana Beach CA, US
Donald J. Skalitzky - San Diego CA, US
John H. Tatlock - San Diego CA, US
Michael D. Varney - Solana Beach CA, US
Scott C. Virgil - San Diego CA, US
Stephen E. Webber - San Diego CA, US
Stephen T. Worland - Del Mar CA, US
Mark Barvian - Ann Arbor MI, US
Gary Bolton - Ann Arbor MI, US
Jeffrey J. Machak - Shelby Township MI, US
Tod Holler - Ann Arbor MI, US
Sean T. Murphy - Ypsilanti MI, US
Michael Melnick - Ann Arbor MI, US
Vara Prasad Josyula - Ann Arbor MI, US
Assignee:

Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:

C07D 207/16
C07D 221/02
US Classification:

546112, 546146, 548540, 514423
Abstract:

Compounds of the formula:.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same
view source
US Patent:

7473790, Jan 6, 2009
Filed:

May 8, 2006
Appl. No.:

11/382154
Inventors:

Allen Borchardt - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:

Pfizer Inc. - New York NY
International Classification:

C07D 309/30
C07D 305/00
C07D 309/00
US Classification:

549291, 549263, 549273
Abstract:

The invention relates to compounds of the formula 1.

Pyrazole Compounds As Raf Inhibitors
view source
US Patent:

7772246, Aug 10, 2010
Filed:

Jul 30, 2008
Appl. No.:

12/182977
Inventors:

Jingrong Jean Cui - San Diego CA, US
Judith Gail Deal - Wildomar CA, US
Danlin Gu - San Diego CA, US
Chuangxing Guo - San Diego CA, US
Mary Catherine Johnson - San Diego CA, US
Robert Steven Kania - San Diego CA, US
Susan Elizabeth Kephart - San Diego CA, US
Maria Angelica Linton - San Diego CA, US
Indrawan James McAlpine - San Diego CA, US
Mason Alan Pairish - San Diego CA, US
Cynthia Louise Palmer - La Mesa CA, US
Assignee:

Pfizer Inc. - New York NY
International Classification:

A61K 31/505
US Classification:

514275, 544331, 546113, 5483731
Abstract:

The present invention is directed to compounds of Formula (I),.

Pharmaceutical Compositions And Methods For Their Use
view source
US Patent:

20040224960, Nov 11, 2004
Filed:

Feb 17, 2004
Appl. No.:

10/783117
Inventors:

Allen Borchardt - San Diego CA, US
Peter Dragovich - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Linton - San Diego CA, US
John Tatlock - San Diego CA, US
Assignee:

Agouron Pharmaceuticals, Inc.
International Classification:

A61K031/519
US Classification:

514/259310
Abstract:

The present invention relates to pharmaceutical compositions and to methods for their use in decreasing cytochrome P450 (CYP450) enzyme activity. The present invention also relates to methods of increasing the bioavailability of a compound in a mammal. Additionally, the present invention relates to methods of decreasing the metabolism of certain compounds in a mammal that are metabolized by the cytochrome P450 enzyme. Furthermore, the present invention relates to pharmaceutical compositions comprising at least one compound metabolized by at least one cytochrome P450 enzyme and a cytochrome P450 enzyme-inhibiting amount of a compound of formula (I).

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same
view source
US Patent:

20050176701, Aug 11, 2005
Filed:

Nov 19, 2003
Appl. No.:

10/718337
Inventors:

Allen Borchardt - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Linton - San Diego CA, US
John Tatlock - San Diego CA, US
International Classification:

C07D417/02
C07D413/02
C07D045/02
A61K031/541
A61K031/5377
A61K031/496
A61K031/452
A61K031/4025
US Classification:

514227500, 514231200, 514254100, 514326000, 514422000, 514460000, 544060000, 544149000, 544374000, 546207000, 548516000, 549292000
Abstract:

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, Rand R, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

Hiv Protease Inhibitors, Compositions Containing The Same, Their Pharmaceutical Uses And Materials For Their Synthesis
view source
US Patent:

20050250707, Nov 10, 2005
Filed:

Jun 20, 2005
Appl. No.:

11/155568
Inventors:

Stacie Canan Koch - La Jolla CA, US
Therese Alexander - San Diego CA, US
Benjamin Burke - San Diego CA, US
Tanya Jewell - Encinitas CA, US
David Kucera - Del Mar CA, US
Maria Linton - San Diego CA, US
Lennert Mitchell - Chula Vista CA, US
Siegfried Reich - Solana Beach CA, US
Donald Skalitzky - San Diego CA, US
John Tatlock - San Diego CA, US
Michael Varney - Solana Beach CA, US
Scott Virgil - San Diego CA, US
Stephen Webber - San Diego CA, US
Stephen Worland - San Diego CA, US
Mark Barvian - Ann Arbor MI, US
Gary Bolton - Ann Arbor MI, US
Frederick Boyer - Canton Township MI, US
Jeffrey Machak - Shelby Township MI, US
Tod Holler - Ann Arbor MI, US
Sean Murphy - Ypsilanti MI, US
Michael Melnick - Ann Arbor MI, US
Vara Josyula - Ann Arbor MI, US
International Classification:

A61K038/04
A61K031/426
A61K031/421
A61K031/401
C07K005/04
US Classification:

514019000, 514365000, 548200000, 548531000
Abstract:

Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.